Streamline Health (STRM) Merger: Shares Converted to $5.34 Cash; Warrants Canceled
Rhea-AI Filing Summary
Streamline Health Solutions director Justin J. Ferayorni reported dispositions tied to a merger that became effective on 08/12/2025. Under the Merger Agreement, each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash, and the company became a wholly owned subsidiary of Mist Holding Co.
The Form 4 lists dispositions of common stock held directly and indirectly (reported as 78,416 shares direct and 92,294 shares indirect via Tamarack Advisers) and reports cancellation of 29,914 warrants with a $5.85 exercise price. The filing notes that warrants with exercise prices equal to or above the $5.34 Merger Consideration were canceled for no consideration and shows reported post-transaction beneficial ownership of the listed securities as 0.
Positive
- Merger provided immediate cash consideration of $5.34 per outstanding common share, delivering liquidity to shareholders.
- The Merger Agreement explicitly specifies treatment of warrants, providing clarity on cash conversion or cancellation outcomes for holders.
Negative
- Outstanding warrants with an exercise price equal to or above $5.34 (including 29,914 at $5.85) were canceled for no consideration.
- The company became a wholly owned subsidiary and listed common shares were canceled, eliminating ongoing public equity positions for holders
Insights
TL;DR: Merger completed; public shares converted to $5.34 cash and outstanding warrants were either cashed out or canceled, ending public equity positions.
The Form 4 documents a change-of-control transaction effective 08/12/2025 in which Streamline Health became a wholly owned subsidiary of Mist Holding Co. Each outstanding common share was converted into the right to receive $5.34 in cash. Reported dispositions include 78,416 direct shares and 92,294 indirect shares. The filing also records 29,914 warrants at a $5.85 exercise price; per the Merger Agreement, warrants with exercise prices equal to or above the Merger Consideration were canceled for no consideration. This is a material corporate liquidity event that resolves public holders’ exposure by cash settlement.
TL;DR: Insider filings show director-level holdings held via adviser and family trust were disposed in the merger, with post-transaction ownership reported as zero.
The Form 4 attributes indirect holdings to Tamarack Advisers, LP and direct holdings to The Ferayorni Family Trust, with Mr. Ferayorni identified as managing member/co-trustee. The report indicates the listed common stock positions were canceled and converted into cash, and related warrants were canceled per contract terms. The disclosure is specific about ownership pathways and post-transaction balances, showing no remaining reported beneficial ownership of the listed securities.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Warrant (right to buy) | 29,914 | $0.00 | -- |
| Disposition | Common Stock, $0.01 par value | 78,416 | $0.00 | -- |
| Disposition | Common Stock, $0.01 par value | 92,294 | $0.00 | -- |
Footnotes (1)
- This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration"). The securities are held in the account of Tamarack Advisers, LP (the "Holder") and may be deemed to be beneficially owned by Justin J. Ferayorni, the managing member of the general parter of the Holder. The Issuer effected a 1-for-15 reverse stock split of its common stock on October 4, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split. Pursuant to the terms of the Merger Agreement, at the Effective Time, each warrant to purchase shares of Common Stock (each, a "Company Warrant") that was outstanding and unexercised and had a per share exercise price that was less than the Merger Consideration was canceled and converted into the right to receive (i) a cash payment equal to (A) the number of shares of Common Stock subject to the Company Warrant immediately prior to the Effective Time multiplied by (B) the excess, if any, of (x) the Merger Consideration over (y) the exercise price per share of Common Stock of such Company Warrant, less applicable withholding taxes. Each Company Warrant that was outstanding and unexercised with a per share exercise price that was equal to or greater than the Merger Consideration was canceled for no consideration. The reported securities are owned directly by The Ferayorni Family Trust for which Mr. Ferayorni serves as co-trustee.
